CD53 and metabolic dysfunction-associated steatohepatitis: In vivo, targeted germline CD53 deletion protected against Western diet (WD)–induced hepatic inflammatory gene expression, and NASH diet–induced peripheral fat, hepatic lipid accumulation, and insulin intolerance.